MSCI印尼ETF-iShares EIDO 深 滬
等待開盤 11-26 09:30:00 美东时间
18.73
-0.050
-0.27%
華盛通- 最 高18.80
- 今 開18.72
- 成交量 50.30万股
- 最 低 18.67
- 昨 收 18.78
- 總市值 3.13亿
- 52周最高 20.0581
- 市盈率 靜 --
- 換手率 3.01%
- 52周最低 13.7203
- 委 比 33.33%
- 總股本 1670.00万
- 歷史最高 26.3244
- 量 比 1.00
- 振 幅 0.69%
- 歷史最低 8.5803
- 每 手 1
- 風險率 1.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股ETF日报 | 金价创12年来最大跌幅！做空金矿ETF集体上涨；三倍做多航空与国防产业ETF涨超5%
金价创12年来最大跌幅！做空金矿ETF集体上涨，GDXD涨超28%、JDST涨超20%；雷神绩后大涨7%带飞国防板块，三倍做多航空与国防产业ETF涨超5%>>
10-22 14:47
White House Says Trump Will Hold Multilateral Meeting With Qatar, Saudi Arabia, Indonesia, Turkey, Pakistan, Egypt, The UAE And Jordan
https://www.youtube.com/watch?v=iQa3rY9fu94
09-23 01:18
养生堂集团下护肤品牌推出小分子无创水光仪2.0｜最前线
近年来，家用美容仪市场持续高速增长，年复合增长率超过30%，成为美妆个护领域最具潜力的赛道之一。据公开数据显示，2024年面部美容工具线上市场规模已达89.4亿...
08-30 15:52
President Trump Posts "Expect Trump Executive Action In Next Few Days, Will Explain Trans-Shipment Rules At That Point; Indonesia Will Drop Its Effort To Tariff The Internet, And Immediately Back Renewal Of E-commerce Moratorium At The WTO; Indonesia Will Remove Pre-shipment Inspection Requirements Of U.S. Farm Products That Had Been A Big Obstacle; Goods That Are Trans-Shipped Will Still Face A Tariff Of 40%; Indonesia Will Also Agree To Exempt U.S. Companies From Local Content Requirements"
https://truthsocial.com/@realDonaldTrump/posts/114898507608732258
07-23 03:27
Trump announces trade deal with Indonesia
A trade deal between the U.S. and Indonesia has been inked, U.S. President Donald Trump said on Tuesday. "Great deal, for everybody, just made with Indonesia. I dealt directly with their highly respe...
07-15 22:27
Earlier: President Trump Posts On Truth Social "Great deal, for everybody, just made with Indonesia. I dealt directly with with their highly respected President. DETAILS TO FOLLOW!!!"
https://truthsocial.com/@realDonaldTrump/posts/114857569436636352
07-15 22:14
美股ETF日报 | 英伟达欲进军量子计算！两倍做多QBTS大涨14%；2倍做多HOOD ETF涨超8%
英伟达欲进军量子计算！两倍做多QBTS大涨14%；Robinhood收涨超4%，2倍做多HOOD ETF涨超8%>>
05-20 16:48
阿斯利康(AZN.US)PD-L1+CTLA-4组合在华申报上市 一线治疗NSCLC
2月21日，CDE网站显示，阿斯利康(AZN.US)的PD-L1单抗度伐利尤单抗在华申报新适应症。
02-21 21:24
